Les Meilleurs Cancer des ovaires pour le traitement de cancer des ovaires en Espagne - TOP-4 des médecins

Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.

He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.

Investigatrice principale de nombreux essais cliniques sur les cancers de l'ovaire, du col de l'utérus et de l'endomètre – le Dr Oaknin intègre la recherche de pointe directement aux soins des patientes.

• Experte de premier plan en angiogenèse et réparation de l'ADN pour les cancers gynécologiques
• Auteure de plus de 100 publications et présentations en oncologie
• Co-présidente du GEICO, le groupe de recherche espagnol sur le cancer de l'ovaire
• Membre active de l'ESMO, de l'ASCO et de la SEOM

Le Dr Joseba Rebollo Liceaga apporte plus de 30 ans d'expérience en oncologie, se spécialisant dans les traitements avancés du cancer de l'ovaire à Quironsalud Torrevieja.

• Chef du service d'oncologie à la Clínica San Miguel de Navarra pendant 13 ans
• Recherches publiées sur les techniques innovantes d'électrochimiothérapie
• Diplômé du prestigieux programme de médecine de l'Université de Navarre
• Spécialiste en oncologie médicale de la Clínica Universidad de Navarra

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.